Of note, these results differed from studies in non-small cell lung cancer, urothelial carcinoma, and cervical carcinoma where the authors found significant clinical and molecular differences between the PD-L1(+) and PD-L1(−) groups.35-37. This evidence concerns the gene CD274 and cervical carcinoma.